Future studies may look at targeting the CD40 pathway as a potential therapeutic target ORLANDO, DECEMBER 7, 2025 - Researchers at The University of Texas MD Anderson Cancer Center have characterized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback